Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines

BACKGROUND: Compound Kushen injection (CKI) is a commonly used anti-tumor Chinese patent medicine, which is extracted from Kushen (Radix Sophorae Flavescentis) and Baituling (Rhizoma Smilacis Glabrae) and has been widely prescribed as an add-on therapy to platinum-based chemotherapy (PBC) for advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongwei, Yao, Xiaojun, Li, Ting, Lam, Christopher Wai-Kei, Zhang, Huixia, Wang, Jue, Zhang, Wei, Leung, Elaine Lai-Han, Wu, Qibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946292/
https://www.ncbi.nlm.nih.gov/pubmed/31876753
http://dx.doi.org/10.1097/MD.0000000000018552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946292/
https://www.ncbi.nlm.nih.gov/pubmed/31876753
http://dx.doi.org/10.1097/MD.0000000000018552

Ejemplares similares